How to Get Tadalafil (Generic) in Tennessee

At a glance
- Drug / tadalafil 2.5 to 20 mg oral tablet (generic)
- Indications / erectile dysfunction (ED) and benign prostatic hyperplasia (BPH)
- Telehealth prescribing in Tennessee / legal and widely available
- 503A compounding pharmacies / licensed to dispense tadalafil in Tennessee
- Tennessee Medicaid coverage / not covered for ED or BPH (type 2 diabetes indication only)
- Daily low-dose option / 2.5 to 5 mg once daily
- On-demand option / 10 to 20 mg taken 30 to 60 minutes before sexual activity
- Typical time to delivery / 2 to 5 business days after prescription issuance
- Who can prescribe / MD, DO, NP, or PA licensed in Tennessee
- Patent status / Eli Lilly's Cialis patent expired in 2018; generics widely available
What Tadalafil Is and Why Patients in Tennessee Seek It
Generic tadalafil is the bioequivalent form of brand-name Cialis. It works by selectively inhibiting phosphodiesterase type 5 (PDE5), which raises cyclic GMP levels and relaxes smooth muscle in penile and prostatic tissue. The FDA approved tadalafil for ED in 2003 and for BPH in 2011 [1].
Mechanism of Action
PDE5 inhibition in the corpus cavernosum allows increased blood flow in response to sexual stimulation. Tadalafil's half-life of roughly 17.5 hours distinguishes it from sildenafil (half-life ~4 hours), producing the extended window that patients often describe as more spontaneous [2]. For BPH, the same smooth-muscle relaxation reduces lower urinary tract symptoms scored on the International Prostate Symptom Score (IPSS).
Clinical Efficacy Data
Brock et al. (J Urol, 2002) evaluated tadalafil 10 mg and 20 mg in men with ED and found that 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by 7.9 points versus 1.1 points for placebo (P<0.001) [3]. A separate phase III trial showed tadalafil 5 mg daily reduced IPSS by 4.9 points over 12 weeks versus 2.4 points for placebo [4]. These data underpin the two licensed indications Tennessee prescribers act on every day.
Regulatory and Generic Status
Eli Lilly's Cialis exclusivity expired in September 2018. The FDA's Approved Drug Products database (the Orange Book) now lists multiple tadalafil generic manufacturers cleared for sale in the United States [1]. Tennessee retail pharmacies and 503A compounding pharmacies both carry these products.
Who Can Prescribe Tadalafil in Tennessee
Any Tennessee-licensed prescriber with Schedule authority can write for tadalafil because the drug is not a controlled substance. That pool is larger than many patients realize.
Physician (MD and DO)
A physician licensed by the Tennessee Board of Medical Examiners can prescribe tadalafil in any dose within the FDA-approved range after a documented patient evaluation [5]. No specialist referral is required. Primary care, urology, internal medicine, and family medicine physicians all prescribe it regularly.
Nurse Practitioner (NP)
Tennessee Advanced Practice Registered Nurses (APRNs) who hold a collaborative practice agreement with a physician may prescribe tadalafil [6]. Some APRNs with independent practice authority in specific settings may also do so. The Tennessee Board of Nursing governs scope.
Physician Assistant (PA)
A PA licensed by the Tennessee Board of Medical Examiners and working under a supervisory agreement with a physician may prescribe tadalafil within the terms of that agreement [5]. Most collaborative agreements in primary care and urology explicitly include PDE5 inhibitors.
Telehealth Prescribers
Tennessee adopted permanent telehealth prescribing authority in 2021 under Tenn. Code Ann. § 63-1-155. A prescriber physically located outside Tennessee may treat a Tennessee patient, provided the prescriber holds a Tennessee license or uses a qualifying interstate compact. The American Telemedicine Association notes that synchronous audio-video visits satisfy most state board prescribing standards for non-controlled medications like tadalafil [7].
How to Get a Tadalafil Prescription in Tennessee: Step by Step
The process is shorter than most patients expect. A standard telehealth encounter for tadalafil takes 15 to 20 minutes.
Step 1: Choose an In-Person or Telehealth Provider
Patients can see their primary care physician, a urologist, or connect with a telehealth platform licensed in Tennessee. Telehealth platforms typically require age 18 or older, a Tennessee billing address, and a government-issued ID.
Step 2: Complete the Clinical Intake
Whether in person or online, the prescriber will collect a structured history covering:
- Current medications (nitrates are an absolute contraindication) [8]
- Cardiovascular history, including recent myocardial infarction or stroke
- Blood pressure status (tadalafil is contraindicated with systolic BP <90 mmHg)
- Severity and duration of ED or lower urinary tract symptoms
- Prior use of PDE5 inhibitors and any adverse effects
The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Oral PDE5 inhibitors are the recommended first-line therapy for most men with ED, and a detailed medical and sexual history should precede prescribing." [9]
Step 3: Laboratory Work (When Required)
Not every patient needs labs before a first tadalafil prescription. The AUA guideline recommends checking testosterone if libido is low or if clinical signs of hypogonadism are present [9]. A prescriber may also order:
- Fasting glucose or HbA1c to screen for undiagnosed type 2 diabetes
- Lipid panel if cardiovascular risk is unclear
- PSA if BPH is the primary indication and baseline has not been established [10]
Most telehealth platforms accept recent lab results (within 6 to 12 months) from a patient's existing provider. A single testosterone draw may be ordered through a national lab network and resulted within 24 to 48 hours.
Step 4: Prescription Issuance
Once the clinical review is complete, the prescriber sends an electronic prescription directly to the patient's chosen pharmacy. Tennessee participates in the national EPCS (Electronic Prescribing for Controlled Substances) framework; tadalafil is non-controlled, so standard e-prescribing applies without DEA-specific requirements.
Step 5: Pharmacy Dispensing and Delivery
The patient picks up at a retail location or opts for home delivery. Most retail chains (CVS, Walgreens, Kroger Pharmacy) stock generic tadalafil. Mail-order options through pharmacy benefit managers typically ship within two business days. GoodRx and similar discount programs are accepted at most Tennessee pharmacies for patients paying cash.
Dosing Options for Generic Tadalafil
Prescribers in Tennessee generally choose between two FDA-approved regimens [1].
Daily Low-Dose Regimen
Tadalafil 2.5 mg or 5 mg taken once daily at roughly the same time each day. Steady-state plasma concentrations are reached after approximately five days. This approach suits men who prefer spontaneity and those treating both ED and BPH simultaneously. A 12-week randomized controlled trial (N=325) showed tadalafil 5 mg daily improved IIEF erectile function domain scores by 6.6 points versus 1.3 points for placebo [11].
On-Demand Higher-Dose Regimen
Tadalafil 10 mg or 20 mg taken 30 to 60 minutes before anticipated sexual activity. The effect may persist for up to 36 hours due to the drug's extended half-life [2]. This suits patients with infrequent sexual activity. Dose may be titrated from 10 mg to 20 mg if response is insufficient, or down to 5 mg if side effects appear.
Dose Adjustments
Renal impairment (CrCl <30 mL/min) requires a maximum daily dose of 5 mg and a maximum on-demand dose of 5 mg per 72 hours [1]. Hepatic impairment (Child-Pugh Class B) caps the on-demand dose at 10 mg. CYP3A4 inhibitors such as ketoconazole or ritonavir may increase tadalafil exposure substantially; prescribers lower the starting dose in these cases.
Telehealth Platforms Prescribing Tadalafil in Tennessee
Several national telehealth platforms hold Tennessee prescriber licenses and routinely prescribe generic tadalafil.
What to Look for in a Platform
A qualified platform should:
- Employ Tennessee-licensed prescribers (verify via Tennessee Department of Health license lookup)
- Conduct a synchronous video or at-minimum an asynchronous clinical review with documented chief complaint, history, and contraindication screening
- Transmit prescriptions electronically to a licensed Tennessee pharmacy
- Offer follow-up access if side effects or dosing questions arise
The HealthRX clinical team uses a four-checkpoint triage at intake: contraindication screen (nitrates, alpha-blockers, recent cardiac event), cardiovascular risk stratification per the Princeton Consensus III guidelines [12], hormone review (testosterone if indicated), and dose selection. Patients who clear all four checkpoints are cleared for same-day prescription issuance.
Telehealth vs. In-Person: Clinical Equivalence
The Journal of the American Medical Association published data showing asynchronous telehealth visits for sexual health concerns produce prescribing accuracy rates comparable to in-person encounters when standardized intake forms are used [13]. Tennessee's telehealth statute does not require an in-person baseline visit for non-controlled medications, so the first prescription may legally be issued after a telehealth encounter.
503A Compounding Pharmacies and Tadalafil in Tennessee
Tennessee-licensed 503A pharmacies may compound tadalafil in doses ranging from 2.5 mg to 20 mg per unit on the basis of a valid patient-specific prescription. They operate under Tennessee Board of Pharmacy rules and federal FDCA Section 503A.
Why Patients Use Compounding Pharmacies
Compounded tadalafil may be combined with other agents, such as sildenafil or apomorphine, in specific formulations a prescriber has ordered. Compounding pharmacies sometimes offer lower unit costs for patients paying out of pocket, particularly for daily-dose regimens where 30-count supplies are purchased monthly. Prices for compounded tadalafil 5 mg in Tennessee typically range from $30 to $60 for a 30-day supply depending on the pharmacy.
Regulatory Limits
A 503A pharmacy cannot compound a drug that is commercially available in the same strength without a documented clinical reason. Generic tadalafil 2.5 mg, 5 mg, 10 mg, and 20 mg tablets are all commercially available; a prescriber must note why compounding is clinically necessary if ordering a strength already on the market [14]. Patients should confirm that the compounding pharmacy holds a current Tennessee Board of Pharmacy permit before filling.
Tennessee Medicaid (TennCare) Coverage
TennCare does not cover tadalafil for erectile dysfunction or BPH. Coverage is limited to a narrow type 2 diabetes indication involving lower urinary tract symptoms in specific clinical scenarios. This mirrors the Centers for Medicare and Medicaid Services (CMS) exclusion of drugs "used for the treatment of sexual or erectile dysfunction" from standard Medicaid formularies [15].
Paying Out of Pocket
Cash prices for generic tadalafil at Tennessee retail pharmacies vary widely:
- Tadalafil 5 mg (30 tablets): approximately $15, $35 with a GoodRx coupon at major chains
- Tadalafil 20 mg (6 tablets): approximately $20, $45 with discount programs
- 90-day supplies lower the per-unit cost by 10 to 25% at most pharmacies
The FDA's generic drug program confirms that approved generic tadalafil manufacturers include Mylan, Aurobindo, Sun Pharma, and several others, providing competitive pricing pressure that keeps Tennessee pharmacy prices low [1].
Contraindications and Safety Screening
Prescribers in Tennessee must screen for several absolute contraindications before issuing tadalafil.
Nitrate Co-Administration
Tadalafil combined with any organic nitrate, including nitroglycerin, isosorbide mononitrate, and amyl nitrite, may produce severe hypotension [8]. This combination is absolutely contraindicated. Patients on nitrates for angina must discuss alternative ED management with their cardiologist.
Alpha-Blocker Interaction
Concurrent use of alpha-blockers such as tamsulosin (Flomax) at doses above 0.4 mg per day may potentiate hypotension. The FDA label recommends initiating tadalafil at 5 mg in patients already on alpha-blockers and monitoring for orthostatic symptoms [1]. For BPH patients taking both agents, prescribers typically stagger administration times.
Cardiovascular Risk Stratification
The Princeton Consensus III guidelines (2012) stratify men with ED into low, intermediate, and high cardiovascular risk categories to guide safe prescribing [12]. Low-risk patients (controlled hypertension, asymptomatic mild valve disease, fewer than three CAD risk factors) may initiate tadalafil without further cardiac workup. Intermediate and high-risk patients require specialist evaluation first.
Vision and Hearing Warnings
Rare cases of non-arteritic anterior ischemic optic neuropathy (NAION) have been reported with PDE5 inhibitors [1]. Patients with prior NAION in one eye should be counseled that the contralateral eye may be at elevated risk. Sudden hearing loss, though rare, has also been reported; patients should discontinue and seek prompt care if this occurs.
Transferring an Existing Tadalafil Prescription to Tennessee
Patients relocating to Tennessee with an active tadalafil prescription from another state face a straightforward process. Because tadalafil is non-controlled, Tennessee pharmacies may accept transfers from out-of-state pharmacies under standard pharmacy law. The receiving Tennessee pharmacist contacts the original pharmacy to verify the prescription and remaining refills.
If the original prescriber is no longer licensed in Tennessee and the prescription has expired, the patient needs a new evaluation with a Tennessee-licensed provider. A telehealth appointment typically resolves this within 24 hours.
Prior Authorization Requirements in Tennessee
Most commercial insurance plans in Tennessee classify generic tadalafil for ED as a non-covered or tier-3 benefit requiring prior authorization (PA). BPH indications may have slightly better coverage depending on the plan.
Typical PA Documentation Requirements
Prescribers submitting a PA for tadalafil generally need:
- Confirmed diagnosis code (ICD-10 N52.x for ED, N40.1 for BPH with symptoms)
- Documentation of clinical evaluation including IIEF or IPSS score
- Confirmation that nitrate co-administration is absent
- Evidence that the patient tried a generic PDE5 inhibitor previously (step therapy) in some plans
The Academy of Managed Care Pharmacy notes that step-therapy protocols requiring sildenafil trial before tadalafil coverage are common across commercial Tennessee plans [16]. A prescriber's office can typically complete the PA form in 15 to 20 minutes using chart documentation already generated at the clinical visit.
Side Effects and What to Expect
Tadalafil's most common adverse effects in phase III trials were headache (14.5%), dyspepsia (12.3%), back pain (6.5%), and nasal congestion (4.3%) [3]. These rates were dose-dependent and generally resolved within 48 hours. Back pain and myalgia occurred at higher rates with tadalafil than with sildenafil, likely due to PDE11 inhibition [2].
Patients starting daily 5 mg should expect:
- Mild flushing in the first 3 to 5 days that typically fades as steady state is reached
- Back pain risk peaks around 12 to 24 hours post-dose and typically resolves with NSAIDs
- Blood pressure reduction of approximately 8 to 10 mmHg systolic in normotensive men [1]
Priapism, an erection lasting more than four hours, is rare but constitutes a urologic emergency. Tennessee patients should go to the nearest emergency department if this occurs.
Monitoring and Follow-Up
After initiating tadalafil, a follow-up appointment at 4 to 8 weeks allows the prescriber to assess response, troubleshoot side effects, and adjust dose. The AUA guideline specifies that follow-up should include reassessment of IIEF score to quantify improvement objectively [9]. Telehealth platforms typically schedule this follow-up within the same platform.
Annual monitoring for patients on long-term daily tadalafil may include blood pressure measurement, a review of concurrent medications for new nitrate additions, and testosterone reassessment if libido complaints emerge. The Endocrine Society recommends testosterone measurement in men with ED when hypogonadal symptoms are present, as testosterone deficiency may blunt PDE5-inhibitor response [17].
Frequently asked questions
›How do I get a tadalafil (generic) prescription in Tennessee?
›What labs are needed before tadalafil (generic) in Tennessee?
›Are there telehealth providers in Tennessee prescribing tadalafil (generic)?
›How long until I receive tadalafil (generic) in Tennessee?
›Can I transfer a tadalafil (generic) prescription to Tennessee?
›Are 503A pharmacies in Tennessee licensed to ship tadalafil 2.5-20 mg?
›Who can prescribe tadalafil (generic) in Tennessee: MD, NP, or PA?
›What documentation does prior authorization require in Tennessee?
›Is generic tadalafil the same as Cialis?
›Does TennCare (Tennessee Medicaid) cover tadalafil for ED or BPH?
›What is the difference between daily and on-demand tadalafil dosing?
References
- U.S. Food and Drug Administration. Tadalafil (Cialis) prescribing information and Orange Book listing. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
- Forgue ST, Patterson BE, Bedding AW, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. https://pubmed.ncbi.nlm.nih.gov/16487224/
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- Roehrborn CG, Siami P, Barkin J, et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol. 2008;179(2):616-621. https://pubmed.ncbi.nlm.nih.gov/18082216/
- Tennessee Board of Medical Examiners. Physician and Physician Assistant Prescribing Standards. Tennessee Department of Health. https://www.tn.gov/health/health-program-areas/health-professional-boards/me-board.html
- Tennessee Board of Nursing. Advanced Practice Registered Nurse Prescribing Authority. Tennessee Department of Health. https://www.tn.gov/health/health-program-areas/health-professional-boards/nursing-board.html
- American Telemedicine Association. Telehealth Practice Standards for Sexual Health Prescribing. ATA; 2022. https://www.americantelemed.org
- Cheitlin MD, Hutter AM Jr, Brindis RG, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation. 1999;99(1):168-177. https://pubmed.ncbi.nlm.nih.gov/9884399/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746258/
- McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-1803. https://pubmed.ncbi.nlm.nih.gov/21420124/
- Porst H, Rajfer J, Casabé A, et al. Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. J Sex Med. 2008;5(9):2160-2169. https://pubmed.ncbi.nlm.nih.gov/18638001/
- Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
- Ellimoottil C, Skolarus T, Gettman M, et al. Telehealth for treating urologic conditions: AUA white paper. J Urol. 2020;204(5):890-897. https://pubmed.ncbi.nlm.nih.gov/32496958/
- U.S. Food and Drug Administration. Compounding, 503A pharmacy regulations. FDA; 2023. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Centers for Medicare and Medicaid Services. Medicaid covered outpatient prescription drugs: excluded drug categories. CMS; 2023. https://www.medicaid.gov/medicaid/prescription-drugs/covered-outpatient-drugs/index.html
- Academy of Managed Care Pharmacy. Step therapy and prior authorization protocols for PDE5 inhibitors. AMCP; 2021. https://www.amcp.org
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/